Denis Chem Lab Ltd, established in 1980 and publicly listed in 1982, specializes in the production of sterile intravenous (IV) injectables. The company initially focused on manufacturing IV fluids and bulk drugs, transitioning in 1995 to using BFS technology for IV fluid production in polypropylene bottles. Key products include antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, and irrigation solutions. The production adheres to WHO GMP standards, utilizing advanced automated equipment and facilities.
In 2016, the company expanded its capabilities with a facility for manufacturing IV fluids in PP bottles, boasting an annual capacity of 15 million units. Further expansion in 2021 increased the production capacity of its 100 ml Eurohead 'Aquapulse' line by 12,00,000 bottles monthly. Denis Chem Lab Ltd remains a significant player in the pharmaceutical transfusion solution market, leveraging cutting-edge technologies and expansion projects to enhance its production capabilities.
